Sentences with phrase «lung carcinoma»
"Lung carcinoma" refers to a type of cancer that starts in the cells of the lungs. It is a serious disease where abnormal cells grow uncontrollably and can cause breathing problems and other health complications. Full definition
Inhibition of mutant p53 expression and growth of DMS - 153 small cell lung carcinoma by antagonists of growth hormone - releasing hormone and bombesin.
impactjournals.com
Familial risk of lung carcinoma in the Icelandic population The Journal of the American Medical Association (JAMA)-- Vol.
Bertram JS, Janik P. Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture.
Non-small-cell lung carcinomas in smokers are the predominant form of the disease.
The researchers tested arginine / albumin microspheres on A549, a human lung carcinoma cell line.
Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormonereleasing hormone in combination with docetaxel.
During the study period, all of the mice that received only capsaicin developed lung carcinomas while only half of the mice fed 6 - gingerol did.
The estimation of EGFR mutation status is essential for the identification of non-small cell lung carcinoma (NSCLC) patients who may benefit from treatment with EGFR tyrosine kinase inhibitors (TKIs), and hence for improving therapeutic efficacy.
With lung cancer, for example, it wants to be able to resolve whether a test shows non-small-cell lung carcinoma or small cell lung carcinoma.
Among lung cancer patients; suicide SMR was higher in males (SMR = 8.8), Asians (SMR = 13.7), widowed patients (SMR = 11.6), older patients (70 - 75 years; SMR = 12), patients with undifferentiated tumors (SMR 8.6) or small cell lung carcinoma (SCLC) histology (SMR = 11.2), patients presenting with metastatic disease (SMR = 13.9) and in patients who refused to receive surgical treatment (SMR = 13).
The researchers expanded the relevance of these findings to lung carcinoma, showing that soluble antibodies are generally important in the tumor microenvironment to induce accumulation of MDSCs and promote cancer progression.
This includes thoracic cancers such as mesothelioma, small - cell lung carcinoma (SCLC) and non-small cell lung cancer (NSCLC), for which survival remains very low, and renal cell carcinoma.
Flavopiridol inhibits several cellular kinases and has demonstrated cytostatic and cytotoxic activity in vitro and in vivo in numerous human tumor cell lines and xenograft models (including human breast, prostate, and lung carcinoma) at clinically achievable concentrations.
Antagonists of growth hormone - releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
Assessment of predictive markers and patient stratification for treatment regimens for lung cancer: FGFR1 amplification is a potential driving oncogene in lung squamous cell cancer (SCC), a subtype of non-small cell lung carcinoma (NSCLC).
«The tumors with potential relevance for human cancer biology include osteosarcoma, mammary carcinoma, oral melanoma, oral squamous cell carcinoma, nasal tumors, lung carcinoma, soft tissue sarcomas, and malignant non-Hodgkin's lymphoma.»